GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (OTCPK:SQIDF) » Definitions » Cyclically Adjusted PS Ratio

SQI Diagnostics (SQI Diagnostics) Cyclically Adjusted PS Ratio : 1.49 (As of May. 25, 2024)


View and export this data going back to 2009. Start your Free Trial

What is SQI Diagnostics Cyclically Adjusted PS Ratio?

As of today (2024-05-25), SQI Diagnostics's current share price is $0.0149. SQI Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was $0.01. SQI Diagnostics's Cyclically Adjusted PS Ratio for today is 1.49.

The historical rank and industry rank for SQI Diagnostics's Cyclically Adjusted PS Ratio or its related term are showing as below:

SQIDF's Cyclically Adjusted PS Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.37
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SQI Diagnostics's adjusted revenue per share data for the three months ended in Mar. 2023 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.01 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


SQI Diagnostics Cyclically Adjusted PS Ratio Historical Data

The historical data trend for SQI Diagnostics's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Cyclically Adjusted PS Ratio Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.28 11.37 24.66 - 9.16

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.06 12.71 9.16 9.74 5.31

Competitive Comparison of SQI Diagnostics's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, SQI Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQI Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Cyclically Adjusted PS Ratio falls into.



SQI Diagnostics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

SQI Diagnostics's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0149/0.01
=1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SQI Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, SQI Diagnostics's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=0/122.7021*122.7021
=0.000

Current CPI (Mar. 2023) = 122.7021.

SQI Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 0.000 97.182 0.000
201309 0.000 97.419 0.000
201312 0.000 96.945 0.000
201403 0.000 98.604 0.000
201406 0.001 99.473 0.001
201409 0.001 99.394 0.001
201412 0.000 98.367 0.000
201503 0.001 99.789 0.001
201506 0.003 100.500 0.004
201509 0.002 100.421 0.002
201512 0.002 99.947 0.002
201603 0.003 101.054 0.004
201606 0.003 102.002 0.004
201609 0.007 101.765 0.008
201612 0.004 101.449 0.005
201703 0.002 102.634 0.002
201706 0.001 103.029 0.001
201709 0.001 103.345 0.001
201712 0.003 103.345 0.004
201803 0.001 105.004 0.001
201806 0.001 105.557 0.001
201809 0.003 105.636 0.003
201812 0.001 105.399 0.001
201903 0.002 106.979 0.002
201906 0.002 107.690 0.002
201909 0.002 107.611 0.002
201912 0.001 107.769 0.001
202003 0.001 107.927 0.001
202006 0.001 108.401 0.001
202009 0.001 108.164 0.001
202012 0.000 108.559 0.000
202103 0.001 110.298 0.001
202106 0.001 111.720 0.001
202109 0.000 112.905 0.000
202112 0.000 113.774 0.000
202203 0.011 117.646 0.011
202206 0.002 120.806 0.002
202209 0.002 120.648 0.002
202212 0.001 120.964 0.001
202303 0.000 122.702 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SQI Diagnostics  (OTCPK:SQIDF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


SQI Diagnostics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (SQI Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.